VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
SURGSurgePays, Inc.
$0.41$9M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksSURGEarnings History

SURG logoSurgePays, Inc. (SURG) Earnings History

Net Loss

20 years of earnings data (2006–2025) · Currently unprofitable on a TTM basis

TTM Net Income
-$40M
● Net Loss
TTM EPS (Diluted)
$-1.71
Per share, diluted
YoY EPS Growth
+24.7%
Excellent
Net Margin
-63.3%
After-tax profitability
EPS Growth Rate (CAGR)
1YN/A
3YN/A
5YN/A
10YN/A
Operating Margin-59.9%
Gross Margin-18.6%
Return on EquityN/A
Return on Assets-222.0%
Record Annual Net Income$21MFY2023
Record Quarterly EPS$0.49Q3 2023
Consecutive Profitable Years0years
Q1 2026
Net Income-$12M
EPS (Diluted)$-0.51
YoY Growth+24.7%Excellent
QoQ Growth+13.1%Strong

Loading earnings history...

SurgePays, Inc. (SURG) Earnings Overview

As of June 23, 2026, SurgePays, Inc. (SURG) reported trailing twelve-month net income of -$40M, reflecting +24.7% year-over-year growth. The company earned $-1.71 per diluted share over the past four quarters, with a net profit margin of -63.3%.

Looking at the long-term picture, SURG's historical earnings data spans multiple years. The company achieved its highest annual net income of $21M in fiscal 2023.

SurgePays, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →

Compared to peers including LQDT ($30M net income, 5.9% margin), GSAT (-$11M net income, -3.2% margin), SSTK (-$21M net income, 4.6% margin), SURG has room to improve margins relative to the peer group. Compare SURG vs LQDT →

SURG Earnings vs Peers

Earnings metrics vs comparable public companies

CompanyTTM Net IncomeTTM EPSNet MarginROEYoY GrowthCompare
SURG logoSURGCurrent
-$40M$-1.71-63.3%-+24.7%—
LQDT logoLQDT
$30M$0.945.9%14.6%+38.1%
GSAT logoGSAT
-$11M$-0.09-3.2%-2.4%+74.6%
SSTK logoSSTK
-$21M$-0.584.6%8.3%+23.8%
TMUS logoTMUS
$10.5B$9.5712.4%18.2%+0.6%
LBRDA logoLBRDA
-$2.7B$-19.03--34.5%-407.7%
Best in group
Lowest in group

SURG Historical Earnings Data (2006–2025)

19 years
Fiscal Year Net Income YoY % Operating Income EPS (Diluted) Net Margin Op. Margin
2025-$36M+21.1%-$34M$-1.80-63.3%-59.9%
2024-$46M-321.8%-$42M$-2.39-75.1%-68.6%
2023$21M+3128.6%$19M$1.3815.0%13.8%
2022$-680,763+95.0%$633,785$-0.05-0.6%0.5%
2021-$14M-26.2%-$6M$-3.09-26.5%-11.7%
2020-$11M-26.9%-$10M$-5.02-19.7%-18.6%
2019-$8M-448.1%-$8M$-4.27-32.8%-30.2%
2018-$2M+22.2%-$2M$-0.94-10.1%-10.1%
2017-$2M+57.0%-$2M$-1.30-138.5%-144.7%
2016-$5M-244.3%-$3M$-5.13-139.5%-94.2%
2015-$1M-4112.4%-$1M$-2.01-47.2%-46.6%
2014$33,299+159.9%$31,217$1.781.2%1.2%
2013$-55,624+91.5%$-49,478$-2.97-2966.6%-2638.8%
2011$-655,449-41.8%$-651,939$-34.97-31301.3%-31133.7%
2010$-462,392+66.6%$-425,335$-27.90-9477.2%-8717.7%
2009-$1M-26.0%-$1M$-100.35-9642.2%-9302.5%
2008-$1M-1408.1%-$1M$-91.36-12180.6%-12178.7%
2007$-72,773-255.8%$-72,773$-383.02--
2006$-20,453-$-20,407$-72.02--

Download Data

Export SURG earnings history in CSV or JSON format

Free sign-in required to download data

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

20+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

SURG — Frequently Asked Questions

Quick answers to the most common questions about buying SURG stock.

What is SURG earnings per share (EPS)?

SURG trailing twelve-month (TTM) diluted EPS is $-1.71, reflecting +24.7% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2006 to 2025 is available in the table on this page.

What is SurgePays, Inc.'s net income?

SurgePays, Inc. (SURG) trailing twelve-month net income is $-40M as of 2025. Earnings grew +24.7% year-over-year.

Is SURG profitable?

SURG is not currently profitable on a TTM basis, reporting a net loss of $-40M. Net margin is -63.3%. Investors should monitor for a return to profitability.

What is SURG's earnings growth rate?

SURG compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2006 to 2025.

What are SURG's profit margins?

SurgePays, Inc. net profit margin is -63.3%, operating margin is -59.9%, and gross margin is -18.6%. Below-average margins reflect competitive or cost pressures. Return on Equity is N/A.

Is SURG growing earnings?

Yes, SURG earnings are accelerating — EPS growth of +24.7% exceeds the 5-year CAGR of N/A. TTM net income reached $-40M. Earnings momentum is strengthening.

What was SURG's best earnings year?

SurgePays, Inc.'s highest annual net income on record is $21M, achieved in fiscal year 2023. Earnings history on this page spans 2006 to 2025 and includes all annual and quarterly figures.

What were SURG's earnings last quarter?

SURG's most recent reported quarter was Q1 2026. Net income was $-12M with diluted EPS of $-0.51. For a full breakdown of all quarters, see the quarterly earnings table on this page.

SURG Earnings Over Time (2006–2025)

Net income & EPS — annual and quarterly view